PSA Rising prostate cancer news, info, support

Cancer Risk Increased for Vietnam Vets Who Didn't Spray Agent Orange Herbicide

Even Vietnam veterans who were not involved in spraying Agent Orange experience higher levels of dioxin contamination, which is linked to an increased overall risk of cancer, a study reports.

April 15, 2005— Even Vietnam veterans who were not involved in spraying Agent Orange experience higher levels of dioxin contamination, which is linked to an increased overall risk of cancer, reports a study in the April Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

The study, conducted by a group of U.S. Air Force and other researchers, analyzed cancer rates among nearly 1,500 Air Force veterans who served in Southeast Asia during the Vietnam War, but did not actually spray Agent Orange or other herbicides. The men served as a comparison group in a previous study of cancer risk in veterans of Operation Ranch Hand, the unit responsible for spraying Agent Orange.

Even though they didn't work with Agent Orange, veterans in the comparison group had significant blood levels of TCDD, the highly toxic dioxin contaminant of Agent Orange. The current study was designed to assess whether low-level exposure to TCDD affected the later risk of developing cancer.

Higher blood levels of TCDD were associated with higher rates of cancer in the years after serving in Southeast Asia. For veterans with blood TCDD levels above the median, cancer risk was 60 percent higher than for veterans with lower levels. The increased risk wasn't limited to any specific type of cancer, although much of it was related to digestive and respiratory cancers and of the skin cancer melanoma.

The study also looked at how length of service in Southeast Asia affected cancer risk. Veterans whose time in Southeast Asia was above the median were more than twice as likely to develop prostate cancer, compared to those with shorter tours of duty. Prostate cancer risk was unrelated to TCDD level.

There was also a significant interaction between duration of service and dioxin contamination-veterans who served longer in Southeast Asia tended to have higher blood levels of TCDD. Cancer risk was highest for vets who spent more than 2 years in Southeast Asia and had TCDD levels above the median.

TCDD and other dioxins have been linked to cancer and a wide range of other health problems. A recent study found increased rates of cancer-specifically prostate cancer and melanoma-in Air Force veterans who sprayed Agent Orange during the Vietnam War. That study also suggested possible increases in cancer risk in the comparison group of Air Force veterans who served in Southeast Asia but did not spray Agent Orange.

The new results support the finding of increased cancer rates for veterans with higher TCDD levels, even though they weren't directly exposed to Agent Orange. TCDD may promote the development of cancer even at very low levels of exposure. Another possible explanation is that blood TCDD levels reflect some other, unknown risk factor.

The interaction between cancer risk, TCDD levels, and time served in Southeast Asia suggests that a combination of factors are involved. More research will be needed, including longer follow-up of Vietnam-era veterans and more detailed information on their individual tours of duty in Southeast Asia.

ACOEM, an international society of 6,000 occupational physicians and other health care professionals, provides leadership to promote optimal health and safety of workers, workplaces, and environments.

The study is published under the title: Did TCDD Exposure or Service in Southeast Asia Increase the Risk of Cancer in Air Force Vietnam Veterans Who Did Not Spray Agent Orange?
Journal of Occupational & Environmental Medicine. 47(4):335-342, April 2005.
Pavuk, Marian MD, PhD; Michalek, Joel E. PhD; Schecter, Arnold MD, MPH; Ketchum, Norma S. MS; Akhtar, Fatema Z. MS; Fox, Karen A. MD


Recent prostate cancer news

Find Life-Threatening Prostate Cancer by Measuring PSA Velocity During a "Window of Curability" Nov 1, 2006

No specific PSA value predicts clinically significant prostate cancer Some significant tumors occur at low PSA levels. July 2005

Erectile dysfunction goes untreated among many prostate cancer survivors. Oct 8, 2006

New Prostate Cancer Marker, AZGP1, May Identify Prostate Cancer That's Likely To Spread. Oct 4 2006.

Genome-Wide Linkage Study of Prostate Cancer Among African American Men, Results Oct 13 2006.

Provenge prostate cancer vaccine linked to longer survival for asymptomatic hormone refractory stage. June 28, 2006.

Survival Benefit and Safety Profile of PROVENGE in Men with Advanced Prostate Cancer June 29, 2006

Pomegranate, photo by veredgf, stockxchne.huPomegranate Juice Slows PSA Rise in men With Recurrent Prostate Cancer After Surgery, Radiation July 1, 2006

Vitamin D in Activaterd Form May Reduce Blood Clots In Cancer Patients Sept 25, 2006

Vitamin D for prostate cancer patients with PSA relapse

Omega-6 fatty acids hasten growth of prostate cancer cells Feb 10, 2006

Low PSA Nadir and Longer Time to Nadir After Radiation Can Predict Freedom From Prostate Cancer Return March 16, 2006

This page made and last edited by J. Strax, November 15, 2006.

Information on this website is not intended as medical advice nor to be taken as such. Consult qualified physicians specializing in the treatment of prostate cancer. Neither the editors nor the publisher accepts any responsibility for the accuracy of the information or consequences from the use or misuse of the information contained on this web site.

Wear blue Prostate Cancer Awareness ribbon!About Us | Site Archive | Content Policy/Disclaimer | Privacy Policy



HON code symbol

We subscribe to the HONcode principles.
Verify here.

I Can Cope program for cancer patients and their families